Target Pilot KPIs

Measurable outcomes we commit to tracking from Day 1 of the pilot

↓ [X]%
30-Day Readmission Rate
↑ [X]%
Follow-Up Completion Rate
↓ [X] min
Clinician Time per Handoff
[X]%
Clinician Satisfaction Score
Phase 1 — Months 1-3

Single Hospital Proof of Concept

Deploy TracHeal at one DHA hospital (e.g., Rashid Hospital or Dubai Hospital) targeting the cardiology and diabetes discharge pathway — the two highest-volume chronic disease readmission categories in the UAE.

Scope

  • 200-patient cohort (cardiology + diabetes discharges)
  • Text-based input: care coordinators paste discharge summaries
  • AI generates unified care timeline + gap alerts
  • Two-tier alerts: care coordinator dashboard + patient SMS
  • Weekly data review with hospital clinical team

Success Criteria

  • Follow-up completion rate baseline established and improvement measured
  • 30-day readmission rate tracked vs. historical baseline
  • Clinician usability score ≥ 7/10 (SUS survey)
  • Zero patient safety incidents related to AI output
  • Average alert response time < 24 hours
Phase 2 — Months 4-6

Multi-Hospital Expansion + Wareed Integration

Scale to 3 DHA hospitals and integrate with Wareed (DHA's unified health information system) for automated data ingestion — eliminating manual paste workflow.

Scope

  • Expand to 3 DHA facilities across Dubai
  • Add specialties: pulmonology, nephrology, orthopaedic surgery
  • FHIR API integration with Wareed for automated discharge data pull
  • Patient-facing mobile notifications (Arabic + English)
  • Care coordinator dashboard with multi-hospital view

Success Criteria

  • Wareed FHIR integration operational with < 5 min data latency
  • Measurable readmission reduction vs. Phase 1 baseline
  • Patient engagement rate ≥ 40% (responded to at least 1 alert)
  • Cross-hospital referral visibility demonstrated
  • MOHAP preliminary regulatory review initiated
Phase 3 — Months 7-12

Cross-Network Expansion + Commercial Launch

Expand beyond DHA to private hospital groups (e.g., Aster DM Healthcare, Mediclinic Middle East) and begin multi-emirate rollout. Regulatory alignment with MOHAP for commercial deployment.

Scope

  • Onboard 2-3 private hospital groups as paying customers
  • Multi-EHR integration (Epic, Cerner, local systems)
  • Abu Dhabi (DOH) and Sharjah expansion
  • Insurance company data partnerships for outcome tracking
  • Full MOHAP regulatory compliance certification

Success Criteria

  • First commercial contracts signed (B2B SaaS)
  • Demonstrated ROI: cost savings > subscription cost for each hospital
  • Cross-network referral tracking operational
  • Published pilot outcomes (peer-reviewed or conference paper)
  • Series A / grant funding pipeline established

Key Risks and Mitigations

Anticipated obstacles and our plan to address them

Risk Impact Mitigation
EHR integration delays High Phase 1 uses manual text input (no integration dependency). Wareed integration begins in Phase 2 with DHA technical liaison.
Clinician adoption resistance Medium Co-design with care coordinators from Week 1. TracHeal fits into existing workflow — not a new tool, but intelligence layered onto current discharge process.
Data privacy regulatory block High All data stays within DHA network boundary. Privacy-by-design architecture reviewed by DHA information governance team before pilot launch.
AI hallucination / incorrect alerts High Clinician-in-the-loop: every AI output reviewed by care coordinator before action. RAG architecture grounds outputs in source documents. Alert links to original record.
Low patient engagement with alerts Medium Multilingual alerts (Arabic + English). SMS as default channel (highest reach in UAE). Caregiver opt-in for elderly patients.

UAE Regulatory Context

DHA (Dubai Health Authority)

Regulator for all healthcare facilities in Dubai. Sets quality KPIs including readmission targets. Operates Wareed (unified HIS). TracHeal aligns with DHA's digital health transformation strategy.

MOHAP (Ministry of Health)

Federal regulator. UAE Federal Law No. 2 of 2019 governs health data protection. MOHAP approval required for commercial health AI deployment. Phase 3 includes formal regulatory submission.